Usefulness of the bilirubin/albumin ratio for predicting bilirubin-induced neurotoxicity in premature infants

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 93, Issue 5, 2008, Pages

  Hulzebos, C V ^a   Van Imhoff, D E ^a   Bos, A F ^a   Ahlfors, C E ^b   Verkade, H J ^a   Dijk, P H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BILIRUBIN;

GESTATIONAL AGE; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; NEUROTOXICITY; PREMATURITY; PRIORITY JOURNAL; REVIEW;

BILIRUBIN; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; KERNICTERUS; PHOTOTHERAPY; PREDICTIVE VALUE OF TESTS; SERUM ALBUMIN;

EID: 51449106517     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2007.134056     Document Type: Review

References (41)

1. Watchko JF, Maisels MJ. Jaundice in low birthweight infants: pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed 2003;88:F455-8.
2. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316. Erratum in: Pediatrics 2004;114:1138.
3. Oh W, Tyson JE, Fanaroff AA, et al. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics 2003;112:773-9.
4. Shapiro SM. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 2005;25:54-9.
5. Maisels MJ, Watchko JF. Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2003;88:F459-63.
6. Ostrow JD, Pascolo L, Shapiro SM, et al. New concepts in bilirubin encephalopathy. Eur J Clin Invest 2003;33:988-97.
7. Ahlfors CE, Shapiro SM. Auditory brainstem response and unbound bilirubin in jaundiced (jj) Gunn rat pups. Biol Neonate 2001;80:158-62.
8. Ostrow JD, Pascolo L, Tiribelli C. Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitro. Pediatr Res 2003;54:98-104.
9. Calligaris SD, Bellarosa C, Giraudi P, et al. Cytotoxicity is predicted by unbound and not total bilirubin concentration. Pediatr Res 2007;62:576-80.
10. Wennberg R, Ahlfors C, Bhutani V, et al. Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006;117:474-85.
11. Odell GB, Cukier JO, Ostrea EM Jr, et al. The influence of fatty acids on the binding of bilirubin to albumin. J Lab Clin Med 1977;89:295-307.
12. Robertson A, Karp W, Brodersen R. Bilirubin displacing effect of drugs used in neonatology. Acta Paediatr Scand 1991;80:1119-27.
13. Bhutani VK, Johnson LH. Urgent clinical need for accurate and precise bilirubin measurements in the United States to prevent kernicterus. Clin Chem 2004;50:477-80.
14. Kaplan M, Hammerman C. Understanding severe hyperbilirubinemia and preventing kernicterus: adjuncts in the interpretation of neonatal serum bilirubin. Clin Chim Acta 2005;356(1-2):9-21.
15. Bhutani VK, Johnson LH, Shapiro SM. Kernicterus in sick and preterm infants (1999-2002): a need for an effective preventive approach. Semin Perinatol 2004;28:319-25.
16. Ahlfors CE. Criteria for exchange transfusion in jaundiced newborns. Pediatrics 1994;93:488-94.
17. Hansen RL, Hughes GG, Ahlfors CE. Neonatal bilirubin exposure and psychoeducational outcome. J Dev Behav Pediatr 1991;12:287-93.
18. Cashore WJ. Free bilirubin concentrations and bilirubin-binding affinity in term and preterm infants. J Pediatr 1980;96(3 Pt 2):521-7.
19. Cashore WJ, Oh W. Unbound bilirubin and kernicterus in low-birth-weight infants. Pediatrics 1982;69:481-5.
20. Amin SB, Ahlfors C, Orlando MS, et al. Bilirubin and serial auditory brainstem responses in premature infants. Pediatrics 2001;107:664-70.
21. Brown AK, Kim MH, Wu PY, et al. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 1985;75(2 Pt 2):393-400.
22. Bryla DA. Randomized, controlled trial of phototherapy for neonatal hyperbilirubinemia. Development, design, and sample composition. Pediatrics 1985;75(2 Pt 2):387-92.
23. Scheidt PC, Bryla DA, Nelson KB, et al. Phototherapy for neonatal hyperbilirubinemia: six-year follow-up of the National Institute of Child Health and Human Development clinical trial. Pediatrics 1990;85:455-63.
24. Scheidt PC, Graubard BI, Nelson KB, et al. Intelligence at six years in relation to neonatal bilirubin levels: follow-up of the National Institute of Child Health and Human Development Clinical Trial of Phototherapy. Pediatrics 1991;87:797-805.
25. Kim MH, Yoon JJ, Sher J, et al. Lack of predictive indices in kernicterus: a comparison of clinical and pathologic factors in infants with or without kernicterus. Pediatrics 1980;66:852-8.
26. Ritter DA, Kenny JD, Norton HJ, et al. A prospective study of free bilirubin and other risk factors in the development of kernicterus in premature infants. Pediatrics 1982;69:260-6.
27. Govaert P, Lequin M, Swarte R, et al. Changes in globus pallidus with (pre)term kernicterus. Pediatrics 2003;112(6 Pt 1):1256-63.
28. Jacobson J, Wennberg RP. Determination of unbound bilirubin in the serum of newborns. Clin Chem 1974;20:783.
29. Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. J Pediatr 2001;139:317-9.
30. Gartner LM, Snyder RN, Chabon RS, et al. Kernicterus: high incidence in premature infants with low serum bilirubin concentrations. Pediatrics 1970;45:906-17.
31. Watchko JF, Oski FA. Kernicterus in preterm newborns: past, present, and future. Pediatrics 1992;90:707-15.
32. Ahlfors CE, Parker AE. Evaluation of a model for brain bilirubin uptake in jaundiced newborns. Pediatr Res 2005;58:1175-9.
33. Blackmon LR, Fanaroff AA, Raju TN. Research on prevention of bilirubin-induced brain injury and kernicterus: National Institute of Child Health and Human Development conference executive summary. 2003. Pediatrics 2004;114:229-33.
34. Nakamura H, Yonetani M, Uetani Y, et al. Determination of serum unbound bilirubin for prediction of kernicterus in low birthweight infants. Acta Paediatr Jpn 1992;34:642-7.
35. Funato M, Tamai H, Shimada S, et al. Vigintiphobia, unbound bilirubin, and auditory brainstem responses. Pediatrics 1994;93:50-3.
36. Ahlfors CE, Wennberg RP. Bilirubin-albumin binding and neonatal jaundice. Semin Perinatol 2004;28:334-9.
37. Hansen TW. Bilirubin oxidation in brain. Mol Genet Metab 2000;71(1-2):411-17.
38. Tiribelli C, Ostrow JD. The molecular basis of bilirubin encephalopathy and toxicity: Report of an EASL Single Topic Conference, Trieste, Italy, 1-2 October, 2004. J Hepatol 2005;43:156-66.
39. Ostrow JD, Pascolo L, Brites D, et al. Molecular basis of bilirubin-induced neurotoxicity. Trends Mol Med 2004;10:65-70.
40. Gennuso F, Fernetti C, Tirolo C, et al. Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1). Proc Natl Acad Sci U S A 2004;101:2470-5.
41. Falcao AS, Bellarosa C, Fernandes A, et al. Role of multidrug resistance-associated protein 1 expression in the in vitro susceptibility of rat nerve cell to unconjugated bilirubin. Neuroscience 2007;144:878-88.